首页> 外文会议>Conference on advancing manufacture of cell and gene therapies >ADVANCING THE KNOWLEDGE ON IMMUNOMODULATORY PROPERTIES OF HUMAN CARDIAC STEM CELLS
【24h】

ADVANCING THE KNOWLEDGE ON IMMUNOMODULATORY PROPERTIES OF HUMAN CARDIAC STEM CELLS

机译:推进关于人类心脏干细胞的免疫调节特性的知识

获取原文

摘要

Transplantation of allogeneic human cardiac/stem progenitor cells (hCSC) is currently being tested in several phase Ⅰ/Ⅱ clinical trials as a novel and promising therapy for restauration of myocardial tissue function in acute myocardial infarction (AMI) patients. Previous findings demonstrate that these cells have an immune suppressive profile, interacting with different populations from the immune system, resulting in overall attenuation of myocardium inflammation. However, transplanted hCSCs are still recognized and cleared from the injured site impairing long retention times in the tissue that could be translated into a higher clinical benefit. In this work, different models of allogeneic hCSC/ T-lymphocyte interaction in vitro were explored, using the same hCSCs employed in the allogenous hCSCs transplantation phase Ⅰ/Ⅱ clinical trial CARE-MI, NCT02439398. T lymphocytes were cultured either in direct contact with hCSCs, or using transwell inserts or with hCSC conditioned medium. In our results, we show that IFN-γ activation is correlated with an increase in hCSC indoleamine 2,3-dioxygenase (IDO) enzyme expression. We also show a significant inhibition of T lymphocyte inhibition when cultivating human peripheral blood mononuclear cells (hPBMCs) in direct cell-cell contact, using transwells or with activated hCSC conditioned medium, combined with tryptophan depletion and kyurenine (a tryptophan metabolite) accumulation in activated hCSCs conditioned medium. These findings provide evidence, that although playing a role in the process, PDL-1 cell contact dependent T-regulatory cell modulation is not the exclusive neither the central mechanism involved in T-lymphocyte proliferation inhibition. This finding further supports the prominent paracrine-based beneficial CSC activities in the host tissue. Our results demonstrate for the first time that hCSCs exert an immune-suppressive effect on T lymphocyte proliferation through a paracrine mechanism associated with IDO enzyme mediated tryptophan metabolism. The knowledge generated contributes not only to a better understanding on hCSC immunomodulatory mechanisms, but also open new avenues in the development of new hCSC transplantation strategies in allogeneic settings.
机译:异基因人类心脏/干祖细胞(hCSC)的移植目前正在几项Ⅰ/Ⅱ期临床试验中进行测试,作为一种可恢复急性心肌梗死(AMI)患者心肌组织功能的新颖且有希望的疗法。先前的发现表明这些细胞具有免疫抑制特性,可与免疫系统中的不同种群相互作用,从而导致心肌炎症的总体缓解。但是,移植的hCSCs仍能从受伤部位被识别并清除,损害了在组织中的长保留时间,这可能转化为更高的临床益处。在这项工作中,探索了不同的异体hCSC / T淋巴细胞体外相互作用模型,并使用了异种hCSCs移植I / II期临床试验CARE-MI NCT02439398中使用的相同hCSC。将T淋巴细胞与hCSC直接接触,或使用transwell插入物或hCSC条件培养基进行培养。在我们的结果中,我们表明IFN-γ激活与hCSC吲哚胺2,3-二加氧酶(IDO)酶表达的增加有关。当直接培养人外周血单核细胞(hPBMCs),并使用Transwell或活化的hCSC条件培养基,结合色氨酸耗竭和Kyurenine(色氨酸代谢产物)积累时,我们也显示出对人外周血单核细胞(hPBMC)的T淋巴细胞抑制有明显抑制作用。 hCSCs条件培养基。这些发现提供了证据,尽管在该过程中发挥了作用,但PDL-1细胞接触依赖性T调节细胞的调节并不是排他性地抑制T淋巴细胞增殖的中心机制。这一发现进一步支持了宿主组织中显着的基于旁分泌的有益CSC活性。我们的结果首次证明了hCSCs通过与IDO酶介导的色氨酸代谢相关的旁分泌机制对T淋巴细胞的增殖产生免疫抑制作用。产生的知识不仅有助于更好地了解hCSC免疫调节机制,而且为异基因环境中新的hCSC移植策略的开发开辟了新途径。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号